Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GRF analogs and fragments: correlation between receptor binding, activity and structure.

R M Campbell1, Y Lee, J Rivier

  • 1Department of Animal Science, Hoffmann-La Roche Inc., Nutley, NJ 07110.

Peptides
|May 1, 1991
PubMed
Summary

Structural modifications to growth hormone-releasing factor (GRF) analogs, specifically Ala15-substitution, enhance GRF receptor binding and potency. This research clarifies key structural requirements for GRF receptor interaction and activation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproductive performance of lactating dairy cattle after intrauterine administration of a prostaglandin F2α receptor antagonist 4 days after insemination.

Theriogenology·2014
Same author

Identification, by RT-PCR, of eight novel I₂-conotoxins from the worm-hunting cone snails Conus brunneus, Conus nux, and Conus princeps from the eastern Pacific (Mexico).

Peptides·2014
Same author

Synthesis of bis- and tris-branched COOH-terminal pegylating reagents: conjugation to NH-terminal peptides.

The journal of peptide research : official journal of the American Peptide Society·2005
Same author

Synthesis of symmetrically and asymmetrically branched pegylating reagents.

The journal of peptide research : official journal of the American Peptide Society·2004
Same author

Editorial: Bruce Merrifield at the "Crossroads of Chemistry and Biology".

Biopolymers·2002
Same author

The Alzheimer's peptide a beta adopts a collapsed coil structure in water.

Journal of structural biology·2000

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Endocrinology

Background:

  • Growth hormone-releasing factor (GRF) is a peptide hormone that stimulates growth hormone secretion.
  • Understanding the structure-activity relationship of GRF analogs is crucial for developing therapeutic agents.
  • The GRF receptor mediates the biological effects of GRF.

Purpose of the Study:

  • To investigate the impact of specific amino acid substitutions on the binding affinity and activity of human GRF (hGRF) analogs.
  • To elucidate the structural features of hGRF analogs essential for GRF receptor binding and activation.

Main Methods:

  • In vitro assessment of GRF-releasing activity.
  • Measurement of GRF receptor binding affinity for various hGRF analogs.
  • Analysis of peptide fragments representing enzymatic cleavage sites.

Related Experiment Videos

Main Results:

  • GRF-releasing activity directly correlated with GRF receptor binding affinity across all tested hGRF analogs.
  • hGRF(1-29)-NH2 analogs with Ala15 substitution showed 4-5 times higher GRF receptor affinity compared to hGRF(1-44)-NH2.
  • Replacement of Gly15 with Sar15 significantly reduced activity and receptor binding; inactive fragments resulted from diminished receptor binding.

Conclusions:

  • Ala15-substitution in hGRF analogs enhances receptor affinity and potency, likely through increased amphipathic alpha-helical interactions.
  • Specific structural features, including the integrity of the N-terminal region and avoidance of cleavage, are critical for GRF receptor binding and activation.
  • These findings provide a detailed understanding of the structural basis for GRF receptor interaction and biological function.